Ginseng Extracts Market Set for Steady Growth: Projected to Reach USD 18,146.7 Million by 2034

The global ginseng extracts market is set to witness growth at a CAGR of 4.4% and top a valuation of USD 18,146.7 Million by 2034. Ginseng being a herbal supplement, is used to make functional foods with the extract of its root containing active elements called ginsenosides. The product thus naturally has anti-inflammatory and antioxidants qualities, which helps in improving brain function, strengthening immune system of the body, improving erectile dysfunction, and fighting lethargy.

Additionally, ginseng extracts can be used to address various health issues, including different types of cancer, swine flu, anemia, diabetes, gastritis, asthma, and fever. Panax ginseng, in particular, is beneficial for the intestinal tract; however, its efficacy and quality can vary based on bioavailability and the form in which it is consumed. When taken orally, ginsenosides can be challenging to break down due to liver enzymes and gastric juices.

Once the extracts reach the intestine, they are fermented into more bioavailable metabolites by gut microflora, enhancing energy levels and supporting metabolic balance. Consequently, the medicinal properties of ginseng extracts are driving growth in the market as they become increasingly popular as supplements in the food and beverage industry.

Key Takeaways from Market Study

  • The ginseng extracts market is worth of USD 11,842.6 Million sales in 2024.
  • The ginseng extracts market is expected to expand at CAGRs of 4.4% through 2034.
  • Global ginseng extracts demand is projected to grow year-on-year (Y-o-Y) growth of 7.3% in 2024.
  • The ginseng extracts market is growing with a notable boost towards the production to reach USD 18,146.7 Million by 2034.
  • Innovative applications, research formulations, and medicinal properties are the factors driving growth of Ginseng Extracts market to be the influencing factors among consumers, which is driving sales of ginseng extracts across global markets.
  • Demand for ginseng extracts grew at 4.6% CAGR between 2019 and 2023.
  • Korea Ginseng Corp., Clariant, Korean Ginseng Export Corporation, RFI Ingredients, Inc, and Ilhwa Co., Ltd. are expected to be the top players in the industry.
  • Siberian ginseng type with capsule form segment of ginseng extracts are in heavy demand from beverage industry carrying a notable market share.

Competitive Landscape

Key manufacturers of ginseng extracts are concentrating on expanding their product portfolios through new innovations and investing in research and development. Meanwhile, leading brands in the ginseng extracts market are pursuing inorganic growth strategies, establishing a presence in various countries to increase their market share.

For instance

  • February 2024, Ginsa brands officially launched ginsa, the first-to-industry sparkling ginseng tonic centered around Korean red ginseng, an antioxidant-rich root celebrated for its ability to increase energy, enhance immunity, fight inflammation and improve focus.
  • February 2024, South Korean cosmetics startup FM Biohealth Co. launched a new skincare product that contains ginseng fruit extracts as an active substance.

Leading Ginseng Extracts Brands

  • Korea Ginseng Corp.
  • Clariant
  • Korean Ginseng Export Corporation
  • RFI Ingredients, Inc
  • Ilhwa Co., Ltd.
  • Organika Health Products Inc
  • Nature’s Way Products, LLC
  • Orkla Health A/S
  • Shanghai FanPharma Co., Ltd.
  • Koshiro Company Limited
  • Others

Tap into Expertise: Discuss with Our Analyst on Email: sales@futuremarketinsights.com

Key Segments of Market Report

By Product Type:

As per product type the industry has been categorized into American Ginseng, Oriental Ginseng, Siberian Ginseng , Asian Ginseng, Others

By Form:

The segment is further categorized into Powder, Liquid, Tablet, Capsule, Gel and Others

By Application:

Application in further categorized into Food & Beverages, Nutraceuticals & Dietary Supplements, Pharmaceutical, Cosmetics & Personal Care, Others

By Region:

Industry analysis has been carried out in key countries of North America, Latin America, Europe, East Asia, South Asia, Oceania and Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Unlocking Potential: The Growth Trajectory of the Global Pea Milk Market

A recent report by Future Market Insights, a market research and competitive intelligence provider, estimates that sales of pea milk will reach USD 283.5 million by 2032, with a significant growth rate of 10.4% CAGR over the next decade.

Pea milk, made from dry peas, is available in various flavors such as original, unsweetened, vanilla, and chocolate. Its creamy texture and superior health benefits compared to other plant-based milks are key factors driving consumer preference, contributing to the anticipated growth of the pea milk market.

The rising number of vegan and health-conscious consumers globally is significantly boosting the pea milk industry. Additionally, increasing awareness of lactose intolerance, due to insufficient levels of the enzyme lactase, is driving demand for dairy-free and vegan food products. As a result, plant-based milk alternatives are gaining popularity in both mature and emerging markets.

This growth is attributed to a rising number of individuals with dairy allergies. Additionally, increasing health awareness and growing disposable incomes have expanded the pea milk market. The introduction of new healthy ingredients by various market players also plays a significant role in driving this market’s growth.

Key Takeaways from Market Study

  • The United Kingdom is one of Europe’s most promising markets for pea milk. An increasing proportion of the British population will switch to a vegan, vegetarian, or pescatarian diet by 2022.
  • The market for pea milk in the United States is expected to grow rapidly, expanding at a CAGR of nearly 8.2% between 2022 and 2032. The US market is expected to have a market share of 60%.
  • With the outbreak of the COVID-19 pandemic, consumers are re-evaluating and changing their drinking and eating habits. The market is expected to grow at a rate of 9.1% from 2022-2023.
  • PET bottles, which are primarily used in the packaging of drinking water and beverages, are becoming increasingly popular in the pea milk industry.
  • Tetra packs of pea milk are expected to account for 40% of global market demand over the next decade. Sales are being boosted by the high convenience attributed to its lightweight and durability.

Competitive Landscape

Key pea milk manufacturers are emphasizing the penetration of mainstream retail markets by introducing a diverse range of product offerings. In addition, they are focusing on forming alliances with leading players as well as acquisitions.

  • Wunda, a new pea-based beverage from Nestlé, is “epic in everything” that milk is used for. That is, it can be eaten plain, poured over cereal, mixed into hot beverages, frosted, cooked with, and so on.
  • Sproud Original Drink is a plant-based milk that tastes like milk. It is as white as milk and contains no allergens, lactose, nuts, Pea, or genetically modified organisms. Furthermore, it is high in protein and has a very low sugar content. Ideal for a healthy diet.

Key Companies Profiled

  • Ripple Foods
  • Sproud
  • Bolthouse Farms
  • Snappea Foods
  • Qwrkee Foods Ltd
  • Devon Garden Foods
  • VLY Foods
  • Nestle SA
  • Freedom Foods
  • Mighty Pea
  • Drinkstar
  • Asia Pte Ltd

Get Strategic Guidance from Our Analyst Contact us on: +1-347-918-3531

Pea Milk Market by Category

By Flavor, Pea Milk Market is Segmented as:

  • Original Flavored Pea Milk
  • Vanilla Flavored Pea Milk
  • Chocolate Flavored Pea Milk
  • Barista Flavored Pea Milk

By Packaging Material, Pea Milk Market is Segmented as:

  • Tetra Packs
  • PET Bottles

By End-User, Pea Milk Market is Segmented as:

  • Individual Consumers
  • HoReCa
  • Gyms & Cafes

By Sales Channel, Pea Milk Market is Segmented as:

  • Brick & Mortar Stores
  • Online Retail Channels

By Region, Pea Milk Market is Segmented as:

  • North America
  • Latin America
  • Europe
  • Middle east and Africa
  • East Asia
  • South Asia
  • Oceania

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Rising Demand for Convenience Foods Fuels Growth in the Frozen Snacks Market

The global frozen snacks market is set for significant growth between 2023 and 2033. According to a research report by Future Market Insights, the market is projected to exceed a valuation of USD 136,981 million in 2023 and reach approximately USD 250,736.0 million by 2033, reflecting a CAGR of 6%.

This growth is largely driven by increasing consumer demand for convenient foods that offer high nutritional value, enhanced flavors, and diverse options, leading to greater consumption of frozen snacks.

As consumers become more aware of the nutritional content in packaged and frozen foods, brands are responding by adding essential nutrients, vitamins, and minerals to meet this rising demand. Consequently, sales are expected to grow significantly throughout the assessment period.

The growing demand for ready-to-eat meals worldwide is driving manufacturers to introduce unique flavors and ingredients in frozen snacks. By launching nutrient-rich convenience foods that utilize organic components and distinct flavor profiles, they aim to boost market sales.

As consumers embrace diverse diets like vegan, gluten-free, and keto, manufacturers are responding by investing in research and development. This focus includes incorporating clean-label and organic ingredients, along with innovative packaging and branding strategies, to enhance sales. These efforts are expected to create significant growth opportunities in the market.

Key takeaways from Frozen Snacks Market:

  • The global frozen snacks industry size increased at a CAGR of 2.6% from 2018 to 2022.
  • In 2018, the global market size stood at USD 119,050.3 million.
  • The market size stood at USD 131,712.70 million in 2022.
  • In 2022, the meat-based segment garnered a 34.6% share of the global market.
  • In 2022, the supermarkets and hypermarkets segment captured a 27.6% share of the global market.
  • In 2022, China captured a 5.8% share of the global market.
  • In 2022, the United States captured an 18.2% share of the global market.

Competitive Landscape

Key players in the global market are investing heavily in research and development to enhance nutritional value and extend shelf life in their products. They are also pursuing strategic partnerships, mergers, and acquisitions to expand their reach and geographical presence. Additionally, the introduction of new products and superior frozen snack options are integral components of the organic strategies employed by these leading companies.

Recent Developments

  • In May 2023, Bikano, a manufacturer of packaged snacks and snacks, introduced a line of frozen snacks into the global market to increase export sales by 40% year over year. Bikano expects to reach Rs 200 crores in revenue in FY 23–24 as a result of this move as it looks to capitalize on prospects in the global market.
  • In April 2022, Cofresh Snack Foods, a snack company in India, expanded its product line by introducing exotic veggies and innovative frozen Indian snacks. The new line-up includes new products like Batata Vada and Aloo Tikki, which are made with potato and chickpea flour, as well as other well-known Indian street foods like Vegetable Kathi Roll, Tandoori Chilli Potato Kathi Roll, and hand-stretched Tandoori Garlic Naan.

Key Players Working in the Global Market for Frozen Snacks:

  • Nestle’
  • ConAgra Foods Inc.
  • Ajinomoto Co. Inc.
  • McCain Foods
  • The Kraft Heinz Co.
  • Cargill Incorporated
  • Tyson Foods Inc.
  • NewForrest Fingerfood BV
  • Rich Products Corp.
  • Nomad Foods Ltd.
  • Others

Get Connected with Our Expert Analyst on Email: sales@futuremarketinsights.com

Frozen Snacks Market Segmentation

By Product Type:

  • Desserts
  • Confectionery
  • Vegetable & Fruit Snacks
  • Bakery Products
  • Meat Based Snacks
  • Meat Substitute Snacks
  • Seafood Snacks
  • Other Products

By Category:

  • Ready to Eat
  • Ready to Cook
  • Others

By Sales Channel:

  • Offline Sales Channel
    • Supermarkets/Hypermarkets
    • Departmental Stores
    • Convenience Stores
    • Other Sales Channel
  • Online Sales Channel
    • Company Website
    • E-commerce Platform

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • The Middle East & Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Small Molecule CMO/CDMO Market Poised for Robust Growth, Reaching USD 124,532.4 Million by 2034, Says Future Market Insights

The global small molecule CMO/CDMO market is set for impressive expansion, according to the latest report from Future Market Insights (FMI). The market is projected to grow at a robust Compound Annual Growth Rate (CAGR) of 5.2% from 2024 to 2034, reaching an estimated value of approximately USD 74,998.1 million in 2024 and soaring to USD 124,532.4 million by the end of the forecast period.

Small-molecule Active Pharmaceutical Ingredients (APIs) are integral to the pharmaceutical industry, forming the cornerstone of many medications. These APIs are distinguished by their low molecular weights and chemical synthesis, enabling targeted therapeutic effects through precise interactions with biological systems.

The FMI report emphasizes the growing importance of small molecule CMO/CDMO services in meeting the surging global demand for small-molecule APIs. As pharmaceutical companies increasingly seek to outsource operations to streamline processes, enhance operational flexibility, and access specialized expertise, the small molecule CMO/CDMO sector is experiencing notable growth. This trend underscores a broader shift in the industry towards leveraging external partners to drive efficiency and foster innovation.

With the market’s expansion, small molecule CMO/CDMO providers are anticipated to play a crucial role in supporting the evolving needs of the pharmaceutical industry. They will be instrumental in ensuring the efficient production and development of essential small-molecule APIs, thereby contributing significantly to advancements in medication and therapeutic solutions.

Key factors driving the growth of the global small molecule CMO/CDMO market include:

  • Rising Demand for Customized Drug Development: The growing need for tailored therapeutic solutions and personalized medicine is propelling the demand for small molecule CMO/CDMO services, enabling pharmaceutical companies to develop niche products with precision.
  • Advancements in Pharmaceutical Technologies: Technological advancements, particularly in synthetic chemistry, process optimization, and analytical methodologies, are bolstering the efficiency and cost-effectiveness of small molecule CMO/CDMO operations, driving market expansion.
  • Increasing Focus on API Manufacturing Outsourcing: Pharmaceutical companies are increasingly outsourcing API manufacturing to specialized CMOs/CDMOs to capitalize on their expertise, infrastructure, and regulatory compliance, fostering market growth.
  • Expanding Biopharmaceutical Pipeline: The burgeoning pipeline of small-molecule drugs, coupled with patent expirations and generic competition, is fueling demand for CMO/CDMO services for API development, manufacturing, and formulation.

Future Market Insights’ comprehensive analysis offers valuable insights for stakeholders, including small molecule CMOs/CDMOs, pharmaceutical companies, investors, and regulatory authorities, to capitalize on emerging opportunities and navigate challenges in the evolving landscape.

Key Takeaways from the Small Molecule CMO/CDMO Market Study:

  • By product, the standard API segment held a lucrative small molecule CMO/CDMO market share of 7% in 2023.
  • By service, the process development segment is expected to hold over 8% market value share by the end of 2034.
  • By company size, the mid-sized company segment is set to progress at a 8% CAGR, totaling a valuation of USD 55,615.8 million by 2033.
  • By the scale of operation, the commercial segment is set to expand at a high CAGR of 6%, totaling USD 90,027.3 million in 2033.
  • East Asia is considered the leading region, with a value share of 0% at the end of the forecast period.

Small Molecule CMO/CDMO Trends: Find Out More in Our Comprehensive Report Filled with Key Insights!

Competitive Landscape:

Acquisition and expansion among leading companies or brands is the key strategy of renowned manufacturers in the global small molecule CMO/CDMO market. Companies such as Ajinomoto Bio-Pharma Services and Asymchem are aiming to enhance their presence in the market and compete with other players during the estimated years.

Key Companies Profiled:

  • Pfizer CentreOne
  • Baxter BioPharma Solutions
  • Catalent
  • Lonza
  • Syngene International
  • Boehringer Ingelheim
  • Piramal Pharma Solutions
  • Wuxi AppTec
  • Patheon (Thermo Fisher Scientific Inc.)
  • Adare Pharma Solutions
  • Ajinomoto Bio-Pharma Services
  • Ascendia Pharma
  • Asymchem
  • August Bioservices
  • Cambrex
  • Nanoform
  • PCI Pharma Services
  • Quotient Sciences
  • Societal™ CDMO
  • Siegfried Holding AG
  • Corden Pharma International

Following are a handful of examples of acquisitions made by them to be at the top position:

  • In August 2020, Ajinomoto Bio-Pharma Services added a new 8,500-square-meter production facility to its Visakhapatnam, India site, increasing its capability for manufacturing small molecules.
  • In November 2022, Snapdragon Chemistry, a United States-based chemical technology company that offers experience in continuous manufacturing and early-stage chemical process development services to the pharmaceutical and fine chemical industries, was acquired by Asymchem. It is a contract development and manufacturing organization (CDMO) catering to the global pharmaceutical and biotech industry.

Key Market Segments Covered in Small Molecule CMO/CDMO Industry Research:

By Product:

  • Standard API
  • HPAPI

By Service:

  • Process Development
  • Analytical Method Development
  • GMP Manufacturing Service
  • Scale-Up and Tech Transfer
  • Quality Control and Quality Assurance
  • Regulatory Assistance
  • Technology and Innovation

By Company Size:

  • Large
  • Mid-sized
  • Small

By Scale of Operation:

  • Clinical
    • Phase I
    • Phase II
    • Phase III
  • Commercial

By Region:

  • North America
  • East Asia
  • Western Europe
  • Eastern Europe

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

The Rise of Vegan Yogurt: A Healthy Trend Driving Market Growth at 5.8% CAGR

The vegan yogurt market is projected to grow steadily at a CAGR of 5.8% from 2023 to 2033, increasing in value from USD 6.7 billion in 2023 to over USD 11.7 billion by 2033.

  • The rising vegan movement all over the world is contributing to the higher production and sales of vegan consumables, such as yogurt and milk. These products are there to replace dairy products.
  • Vegan yogurt’s popularity with its health benefits provided by higher fiber, calcium, and protein levels is flourishing in its sales.
  • A big chunk of the urban population that doesn’t follow a vegan diet also tries vegan Yogurt because of its taste and health benefits. Vegan yogurt is treated as a super food that is provided in some urban settings.
  • A section of lactose intolerant people also consume vegan yogurt to fulfill their nutritional requirements, while not comprising their vegan diet.
  • Social media and internet trends around veganism are pushing the masses to try the vegan diet once. Furthermore, the exceptional campaigns and top-notch advertising has also helped the vegan yogurt companies in selling products.

Key Points

  1. The United States market is another significant market. The market is anticipated to cross a value of USD 803.6 million by 2033. The regional market is expected to thrive at a CAGR of 5.4% between 2023 and 2033. The growth is attributed to rising veganism and anti-diary movements.
  2. The China vegan yogurt market leads in terms of CAGR and market share. It is expected to thrive at a leading CAGR of 6.9% during the forecast period. The market is likely to reach a value of US$ 5.6 billion by 2033. Growing demand for vegan products, along with the increased lactose intolerant population, is flourishing the sales of vegan yogurt in China
  3. Almond yogurt is likely to thrive in the product category due to its easy availability and high nutritional value. It is expected to thrive at a CAGR of 6.6% during the forecast period.
  4. The household segment tops the end-use category with a CAGR of 3.8% between 2023 and 2033. The growth is attributed to its benefits in the daily diet through increased consumption.

Competitive Landscape

The global vegan yogurt market is highly fragmented, with leading players introducing high-quality, nutrient-rich products. Increasing demand has driven these companies to expand their production capacity, enabling them to accommodate diverse tastes and preferences while preserving nutritional value.

Recent Developments

  • Epigamia, an Indian startup, announced the debut of a dairy-free coconut milk-based yogurt variety that is unsweetened specifically to meet the needs of Indian consumers.
  • Danone has introduced its vegan yogurt under its essential dairy and plant-based products. The product is produced through almond milk and coconut milk.

Key Players

  • Stonyfield Farm, Inc.
  • KaTech
  • Epigamia
  • NANCY’S
  • Daiya Foods Inc
  • Kite Hill
  • Chobani, LLC
  • COYO Pty Ltd.

Get Strategic Guidance from Our Analyst Contact us on: +1-347-918-3531

Key Segments 

By Product Type:

  • Soy Milk Yogurt
  • Coconut Milk Yogurt
  • Almond Milk Yogurt
  • Rice Milk Yogurt

By Flavor:

  • Chocolate
  • Strawberry
  • Banana
  • Pineapple
  • Mango
  • Lemonade
  • Peach

By End Use:

  • HORECA
  • Household

By Sales Channel:

  • Offline Sales Channel
    • Supermarkets/Hypermarkets
    • Departmental Stores
    • Convenience Store
    • Other Sales Channel
  • Online Sales Channel
    • Company Website
    • E-commerce Platform

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific (APAC)
  • The Middle East & Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Ayurvedic Supplement Market Poised for Remarkable Growth, Projected to Reach USD 4,708.2 Million by 2034

The global ayurvedic supplement market is on a trajectory of extraordinary expansion, with industry experts predicting a substantial valuation of USD 4,708.2 million by 2034. This robust growth trajectory underscores a rising global fascination with traditional healthcare practices and natural remedies.

In 2024, the market achieved a noteworthy valuation of USD 1,831.8 million, marking a pivotal milestone in its ascent. Over the next decade, the ayurvedic supplement market is projected to experience a strong Compound Annual Growth Rate (CAGR) of 9.9%, reflecting a steady upward trend in the industry.

Ayurveda, with its deep roots in ancient Indian medicine, has increasingly captured consumer interest as people seek holistic wellness solutions. This surge in market valuation highlights the growing global enthusiasm for traditional healing practices and natural remedies.

Several key factors are driving the impressive growth of the ayurvedic supplement market. There is a heightened awareness of natural and organic products, a growing preference for preventive healthcare, and the increasing popularity of holistic treatment methods. Consumers are turning to ayurvedic supplements for their proven benefits and natural origins, seeking alternatives to conventional medicine.

The projected market expansion is driven by the rising recognition of the efficacy of Ayurvedic supplements in enhancing overall health and wellness. Additionally, an increase in lifestyle-related health concerns and a preference for organic and plant-based products are further fueling demand.

Innovative product developments and strategic collaborations among leading industry players are also contributing to market growth. Companies are expanding their product portfolios and reaching broader consumer bases, creating significant opportunities for innovation, research, and market expansion within the Ayurvedic supplement sector.

As the industry continues to evolve and captivate global attention, stakeholders, investors, and consumers are closely observing this upward trend, anticipating transformative changes in the wellness and healthcare landscape.

Key Takeaways from the Market Study:

  • Nutritional supplements are the leading product segment and are expected to hold a 9% market share in 2024.
  • Capsules/tablets segment is set to lead in the form of ayurvedic supplements with a projected market share of 9% in 2024.
  • By distribution channel, e-commerce is leading in the ayurvedic supplements market, with a forecasted market share of 9% in 2024.
  • Japan is predicted to be one of the leading countries in the market. For the 2024 to 2034 period, Japan’s CAGR is 9.1%.
  • India and China are the other Asian countries marked with potential for the market. For the forecast period, the CAGR for China and India is projected to be 8.8% and 8.1%.

“Several businesses have launched products with nature-inspired components because of the market’s apparent high demand for natural ingredients. Additionally, leading market players are focusing on novel product development with an enhanced formulation that is effective due to increasing concerns among people about the side effects of conventional medication.” opines Sabyasachi Ghosh Associate Vice President at Future Market Insights (FMI).

Increased Interest in Ayurvedic Supplement: Explore Our Detailed Report for Key Trends and Insights!

Market Competition:

There are numerous regional, up-and-coming, and established businesses in the ayurvedic supplement market, which is fragmented. Key players have started product launches and marketing activities to broaden the product line. Some prominent companies in the market.

Recent Developments:

  • In March 2021, the Ayurveda brand Maharishi Ayurveda rolled out its digital advertisement campaign, featuring a celebrity face in Milind Soman to promote the product Amrit Kalash.
  • In February 2020, Dabur India Ltd. brought out Dabur Keratex, a hair oil enriched with ayurvedic ingredients to control dandruff and nourish the dry scalp.
  • In September 2021, NatureCode launched a new range of dry herbs and ayurvedic wellness products.

Key Companies Profiled:

  • Maharishi Ayurveda India Products Private Limited
  • Surya Herbal Ltd
  • Gynoveda Femtech Private Ltd.
  • Herbal Health Solutions
  • Dabur India Limited
  • ‎ Emami Limited.
  • Veloce Herbals Pvt. Ltd.
  • Riaan Wellness Pvt. Ltd.
  • Global Healthfit Retail India LLP
  • ‎ Pharma Science
  • The Himalaya Drug Co.
  • Tactus Nutrascience
  • ‎ Relevium
  • ‎Organic Dehydrated Foods Pvt. Ltd.
  • BACFO PHARMACEUTICALS (India) Ltd.
  • Herbolab India Pvt Ltd
  • Green Cross Health Innovation
  • ManSure
  • Banyan Botanicals

Key Market Segments Covered in Ayurvedic Supplements Industry Research:

By Product:

  • Dietary Supplements
  • Nutritional Supplements
  • Men and Women Health Supplements
  • Ayurvedic Skin Supplements
  • Others

By Form:

  • Capsules/Tablets
  • Powder
  • Syrups
  • Oil and Ointment
  • Other

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Mail Order Pharmacies
  • E-commerce

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Anti-Hangover Supplements Market Poised for Explosive Growth, Valued at USD 6.8 Billion by 2033

The global anti-hangover supplements market is on a remarkable growth trajectory, according to Future Market Insights’ latest industry analysis. Valued at approximately USD 1.9 billion in 2023, the market is projected to expand at a robust Compound Annual Growth Rate (CAGR) of 14.5% throughout the forecast period. This dynamic growth trajectory is expected to elevate the market to an estimated valuation of USD 6.8 billion by 2033.

The surge in demand for anti-hangover supplements is largely driven by the rising global consumption of alcoholic beverages. Key markets such as the United States, China, and Germany are increasingly confronting alcohol-related health issues, transforming alcohol consumption into a prominent medical concern. This trend is particularly evident among younger populations, who are adapting to evolving lifestyles and innovative ingredients in alcoholic beverages.

“With the escalating alcohol consumption and its associated health risks, the demand for effective anti-hangover solutions is skyrocketing,” said at Future Market Insights. “Our research highlights a significant shift towards proactive health measures, with consumers actively seeking reliable supplements to mitigate the adverse effects of alcohol.”

The market’s impressive growth is further bolstered by advancements in supplement formulations, which are increasingly tailored to address specific hangover symptoms and enhance overall well-being. As consumers become more health-conscious and cognizant of the implications of alcohol consumption, the anti-hangover supplements sector is well-positioned for continued innovation and expansion.

The Future Market Insights analysis underscores the evolving landscape of consumer health and wellness, emphasizing the critical role of anti-hangover supplements in meeting the growing demand for effective, preventative solutions.

Key Market Insights:

  • The global anti-hangover supplements market is valued at USD 1.9 billion in 2023, with projections to reach USD 6.8 billion by 2033, exhibiting a CAGR of 14.5% during the forecast period.
  • Increased alcohol consumption globally, particularly among young consumers, is a primary driver for the rising demand for anti-hangover supplements.
  • Countries such as the United States, China, and Germany are witnessing a surge in alcohol-related health issues, further propelling the market growth.
  • Changing consumer preferences towards wine and beer are contributing to the escalating demand for anti-hangover supplements, driven by lifestyle changes and the introduction of innovative ingredients.

The rapid growth of the global anti-hangover supplements market signifies a paradigm shift in consumer behavior and lifestyle choices. As consumers increasingly prioritize health and wellness, the demand for effective solutions to mitigate the adverse effects of alcohol consumption continues to rise.

Anti-hangover Supplement Market Insights: Access Our Full Report for a Deep Dive into Emerging Trends!

Market Competition:

The anti-hangover supplements market is fragmented, and a variety of regional, up-and-coming, and established businesses are operating within it. A unique anti-hangover supplement with improved efficacy has been formulated, and key stakeholders have started promotional activities to introduce it.

  • In September 2022, H-PROOF received a patent for its revolutionary nutraceutical, The Anytime You Drink Vitamin. The edible tablets aid in promoting liver health, alcohol metabolism, and replenishing essential nutrients, allowing the beginning of the day to feel better than usual after ingesting alcohol.
  • In September 2020, Unilever agreed to buy Liquid I.V., a health-science nutrition and Wellness Company based in the United States, with a product line that includes Hydration, Energy, and Sleep; Liquid I.V. offers a 360-degree approach to wellness. In addition, Liquid I.V. is non-GMO, vegan, gluten-free, soy-free, and dairy-free.

Key Companies Profiled:

  • Abbott
  • Bayer AG
  • More Labs
  • Flyby Ventures LLC
  • Cheers Health Inc.
  • Himalaya Wellness
  • Rally Labs LLC
  • Drinkwel, LLC
  • Liquid I.V., Inc.
  • DOTSHOT
  • Toniiq
  • NoDaysWasted
  • Purple TreeLabs
  • LES Labs
  • EZ Lifestyle (Over EZ)
  • DrinkAde
  • Kaplan Laboratory LLC (H-PROOF)
  • Bytox
  • Cheal Hangover Patch
  • Party Patch
  • Rebound Hangover Fix

Key Market Segments Covered in the Anti-hangover Supplement Industry:

By Product:

  • Solutions
  • Tablets/Capsules
  • Powder
  • Patches

By Distribution Channel:

  • Offline
  • Online Stores

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Pharmacy Automation Market Poised for Significant Growth: Projected to Reach USD 13.3 Billion by 2033 A Surge Driven by Robotics and AI

The global pharmacy automation market is on the cusp of a remarkable transformation, with projections indicating a rise from USD 6.1 billion in 2023 to a substantial USD 13.3 billion by 2033. This growth trajectory reflects a robust compound annual growth rate (CAGR) of 8.1% over the forecast period, highlighting the dynamic evolution within this sector.

A major driver of this expansion is the accelerating adoption of robotic systems in pharmacy operations. These cutting-edge technologies are revolutionizing traditional practices by automating critical tasks such as medication dispensing, prescription packaging, and medication transportation. This automation allows pharmacists to shift focus towards clinically oriented activities, including patient counseling and medication management.

The integration of artificial intelligence (AI) and machine learning (ML) is further advancing the pharmacy automation market. AI-powered systems are optimizing pharmacy functions like prescription filling, inventory management, and patient interaction. For example, AI-driven prescription filling systems offer enhanced accuracy and efficiency, significantly reducing human error and streamlining operations.

Cloud-based systems are also transforming the landscape of pharmacy automation. With their cost-effectiveness, ease of implementation, and superior scalability compared to traditional on-premises solutions, cloud-based systems are gaining traction among pharmacies of all sizes. This trend is driving widespread adoption and reshaping the market.

Interoperability remains a key focus within the industry. The seamless communication between pharmacy automation systems and other healthcare IT systems, such as electronic health records (EHRs) and laboratory information systems (LISs), is improving operational efficiency and reducing errors. According to an analyst at FMI, “The growing emphasis on interoperability is enhancing the integration of pharmacy automation systems with other healthcare technologies, fostering further advancements in the sector.”

As the pharmacy automation market continues to evolve, these technological advancements promise to redefine the future of pharmacy operations, delivering improved efficiency, accuracy, and patient care.

Key Takeaways from the Pharmacy Automation Market Report:

  • The global pharmacy automation market is estimated to register a CAGR of 8.1%, reaching a valuation of USD 13.3 billion by 2033.
  • The market grew at a CAGR of 10.2% during the historical period from 2018 to 2022.
  • The United States is anticipated to dominate the global market by registering an 8.3% CAGR during the forecast period.
  • The market in China is anticipated to progress at a CAGR of 8.7% through 2033.
  • The market in Japan is expected to secure a CAGR of 9.3% during the forecast period.

Stay Ahead with Pharmacy Automation: Delve into Our Full Report for Extensive Trends and Insights!

Key Players and Strategies for Success in the Pharmacy Automation Market

In recent years, there has been a surge in investments and collaborations within the industry with venture capital firms and businesses. These strategic partnerships and financial investments aim to accelerate research and development, scale production, and expand market reach.

Recent Developments in the Pharmacy Automation Market

  • In 2023, Omnicell launched its new specialty pharmacy services offering to help health systems establish and optimize specialty pharmacy programs. This service includes a suite of pharmacy automation solutions, such as robotic dispensing systems and cloud-based inventory management software.
  • In 2021, BD launched its new AutoLink IV compounding system. This system automates the compounding of intravenous (IV) medications, reducing the risk of errors and improving the efficiency of pharmacy operations.
  • In 2022, Parata Systems launched its new RxFill 360 dispensing system. This system uses AI and robotics to automate prescription filling, from order entry to labeling.

Key Companies Profiled in the Pharmacy Automation Market:

  • Becton
  • Cerner Corporation
  • Parata Systems LLC
  • Yuyama Co. Ltd
  • PerceptiMed Inc
  • McKesson Corporation
  • Capsa Solutions LLC
  • Omnicell Inc
  • Dickinson and Company
  • Arxium Inc
  • Scriptpro LLC
  • Swisslog Holdings AG
  • Rxsafe LLC

Key Segments in the Pharmacy Automation Market:

By Product:

  • Medication Dispensing Systems
  • Automated Medication Compounding Systems
  • Packaging and Labeling Systems
  • Storage and Retrieval Systems
  • Tabletop Tablet Counters

By End-use Sector:

  • Inpatient Pharmacies
    • Acute Care Settings
    • Long Term Care Facilities
  • Outpatient Pharmacies
    • Outpatient/Fast Track Clinics
    • Hospital Retail Settings
  • Pharmacy Benefit Management Organization and Mail Order Pharmacies
  • Retail Pharmacies

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific Excluding Japan (APEJ)
  • Japan
  • Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Spine Pain Industry Analysis in United States Set for Transformative Growth, Reaching USD 10.962.7 Million by 2033

The spine pain industry analysis in united states is on the cusp of a major expansion, according to a new report by Future Market Insights. Valued at USD 3,962.7 million in 2023, the market is projected to skyrocket to USD 10,962.7 million by 2033, reflecting a substantial Compound Annual Growth Rate (CAGR) of 10.6%.

This remarkable growth is driven by significant demographic and healthcare shifts, including an aging population, rising obesity rates, and an increase in chronic diseases. These factors are reshaping the healthcare landscape, intensifying the demand for effective spine pain treatments and innovative solutions.

“With an increasingly aging population and a rise in chronic pain conditions, the demand for advanced spine pain treatments is at an all-time high,” stated Future Market Insights. “Our industry acknowledges the urgent need for innovative products and technologies to address these challenges effectively.”

Industry leaders are responding to this demand by heavily investing in research and development to deliver cutting-edge solutions that meet the evolving needs of patients. These advancements are not only aimed at alleviating pain but also at enhancing the overall quality of life for individuals suffering from spine-related conditions.

The projected growth of the U.S. spine pain industry offers significant opportunities for stakeholders across the healthcare sector. From medical device manufacturers to healthcare providers, there is a clear chance to contribute to the advancement of spine pain management and improve patient outcomes.

As the industry evolves, stakeholders are encouraged to prioritize collaboration, innovation, and patient-centric approaches to drive sustainable growth and tackle the complex challenges associated with spine pain.

Key Takeaways:

  • The Spine Pain Industry Analysis in United States is expected to grow at a CAGR of 10.6% from 2023 to 2033, reaching a value of USD 10,962.7 million by 2033.
  • The spinal non-fusion segment is expected to grow at the fastest CAGR of 10.5% during the forecast period.
  • Increasing prevalence of chronic pain conditions, such as arthritis and osteoporosis, is driving the growth of the spine pain industry.
  • Rising demand for minimally invasive and non-surgical treatment options is also contributing to market growth.

Key Drivers:

The following are some of the key drivers of growth in the US spine pain industry:

  • Aging population: The aging population is a major driver of growth in the spine pain market, as older adults are more likely to experience spine pain due to age-related wear and tear.
  • Rising obesity rates: Obesity is another major risk factor for spine pain. As obesity rates continue to rise in the US, so too will the demand for spine pain treatment.
  • Increasing prevalence of chronic diseases: Many chronic diseases, such as arthritis and osteoporosis, can also lead to spine pain. As the prevalence of these diseases increases, so too will the demand for spine pain treatment.

Unveil the United States Spine Pain Industry Surge: Read Our Detailed Report for Essential Trends and Insights!

Key Companies Profiled:

  • Zimmer, Inc. (ZimVie Inc.)
  • Medtronic
  • Johnson & Johnson
  • Stryker Corporation
  • Abbott Laboratories
  • Boston Scientific Corporation
  • B Braun (Aesculap, Inc.)
  • Becton, Dickinson and Company
  • Globus Medical
  • Alphatec Spine, Inc.
  • Nevro Corp
  • NuVasive, Inc.
  • Orthofix US LLC.
  • Surgalign Spine Technologies, Inc.
  • Precision Spine, Inc.

United States Spine Pain Business Outlook by Category:

By Product Type:

  • Spinal Fusion
    • Interbody Devices
    • Pedicle Screw System
    • Spinal Plating System
  • Spinal Non-Fusion
    • Annulus Repair Devices
    • Artificial Disc Replacement Systems
    • Interspinous Process Decompression (IPD) Devices
    • Pedicle Screw-based Dynamic Stabilization Systems
  • Vertebral Body Replacement Systems
  • Spinal Cord Stimulation
  • Transcutaneous Electrical Neuromuscular Stimulation (TENS)
  • Spinal Epidural Injection

By Pain Type:

  • Cervical Pain
    • Arm Pain
  • Thoracolumbar Pain
    • Arm Pain
    • Leg Pain
  • Lumbar Pain
    • Leg Pain
  • Sciatic Pain
    • Leg Pain

By End User:

  • Hospitals
  • Specialty Clinic
  • Ambulatory Surgical Centers

By Region:

  • Northeast
  • Midwest
  • Southeast
  • Southwest
  • West

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Peripheral Angioplasty Market Set for Robust Growth, Reaching USD 7.2 Billion by 2033

The global peripheral angioplasty market, valued at USD 3.4 billion in 2023, is projected to more than double, reaching USD 7.2 billion by 2033. This growth reflects a robust compound annual growth rate (CAGR) of 7.7% throughout the forecast period.

Peripheral angioplasty, a minimally invasive procedure designed to treat peripheral arterial disease (PAD), is gaining momentum as a preferred treatment option. PAD, characterized by the narrowing or blockage of blood vessels in the peripheral arteries, primarily affects the legs and is increasingly prevalent among the elderly and individuals with risk factors such as smoking, diabetes, and hypertension.

The procedure involves the insertion of a catheter with a balloon at its tip into the affected artery. Inflation of the balloon expands or clears the artery, restoring normal blood flow. This approach is favored for its minimally invasive nature and effectiveness in improving patient outcomes.

The peripheral angioplasty market’s expansion is driven by several factors, including:

  • Rising Incidence of PAD: The growing prevalence of PAD globally is fueling the demand for effective treatment options.
  • Technological Advancements: Innovations such as drug-coated balloons and drug-eluting stents have enhanced the efficacy of peripheral angioplasty, reducing the risk of restenosis (re-narrowing of the artery) and improving long-term results.
  • Increasing Preference for Minimally Invasive Procedures: Patients and healthcare providers are increasingly opting for minimally invasive treatments, which offer quicker recovery times and reduced complications.

The market landscape is highly competitive, with a mix of established and emerging players striving to capture market share. Companies are focusing on product differentiation, pricing strategies, and innovative marketing efforts to stand out in this growing sector.

As advancements continue and the demand for effective PAD treatments rises, the peripheral angioplasty market is poised for significant growth, offering promising opportunities for both industry stakeholders and patients alike.

Key Takeaways from the Peripheral Angioplasty Market:

  • The peripheral angioplasty industry in the United States is predicted to reach USD 2.3 billion by 2033, increasing at a 6.8% CAGR.
  • The peripheral angioplasty industry in the United Kingdom is estimated to reach a market share of USD 229.3 million, expanding at a CAGR of 4.2% by 2033.
  • During the forecast period, the peripheral angioplasty industry in China is expected to reach a market share of USD 732.1 million, securing an 13.0% CAGR.
  • The peripheral angioplasty industry in Japan is predicted to reach USD 448.8 million by 2033, increasing at a 9.0% CAGR.
  • South Korea’s peripheral angioplasty industry is predicted to achieve a market share of USD 143.7 million, rising at an 8.7% CAGR during the forecast period.
  • With a CAGR of 5.2% from 2023 to 2033, the balloon catheters segment is expected to dominate the peripheral angioplasty industry.
  • With a CAGR of 6.3% from 2023 to 2033, the hospital is expected to dominate the peripheral angioplasty industry.

Peripheral Angioplasty in Demand: Check Out Our Full Report for a Complete Overview of the Trends and Insights!

How Does the Competition Look in the Peripheral Angioplasty Market?

The peripheral angioplasty sector is a very competitive one, with many firms fighting for market share. Several significant participants in this industry comprise Boston Scientific Corporation, Medtronic, Abbott Laboratories, Terumo Corporation, Johnson & Johnson, Cook Medical, B. Braun Melsungen AG, Edwards Lifesciences Corporation, Becton, Dickinson and Company, MicroPort Scientific Corporation, Teleflex Incorporated, W. L. Gore & Associates, “Biotronik SE & Co. KG”, AngioDynamics, Inc.

The main corporations are investing extensively in research and development efforts to develop inventive and creative products with improved reliability, efficacy, and cost.

Tactical alliances and partnerships with other companies are becoming more common in the industry, allowing parties to leverage one another’s strengths and expand their market influence.

Leading firms use consolidation and mergers to strengthen their market position and gain entry into new markets. The sector is expanding significantly in developing economies, particularly in India and China.

To boost their presence in these regions, major companies are expanding their distribution networks and building regional manufacturing sites. They are also concentrating on offering cost-effective solutions to customers in these markets in order to get a competitive advantage.

Key Developments in the Peripheral Angioplasty Market:

In May 2022, Medtronic announced that the IN.PACT™ paclitaxel-coated percutaneous transluminal angioplasty balloon catheter received approval from the U.S. Food and Drug Administration (FDA).

Segmentation Analysis of the Peripheral Angioplasty Market:

By Product:

  • Balloon Catheters
  • Stents
  • Guidewires

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Catheterization Centers

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • The Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube